Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist

21 Sept 2003

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic and Kidney Cyst Diseases
Share to Organ Donation and Transplantation
Share to Renal and related cancers

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 14502283
DOI: 10.1038/nm935

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonistPMID 14502283Read ↗

The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors.Semantic proximity Read ↗

Benzodiazepine Derivatives as Potent Vasopressin V2 Receptor Antagonists for the Treatment of Autosomal Dominant Kidney DiseaseSemantic proximity Read ↗

Unravelling the pathogenesis of cystic kidney diseases.Semantic proximity Read ↗

Therapeutic targets for polycystic kidney disease.Semantic proximity Read ↗

The vasopressin-aquaporin-2 pathway syndromes.Semantic proximity Read ↗

Renal aquaporins and water balance disorders.Semantic proximity Read ↗

[Polycystic kidney disease: Pathogenesis, pathophysiology, and therapy].Semantic proximity Read ↗

Cystic disease of the kidney.Semantic proximity Read ↗

V2 vasopressin receptor mutations: future personalized therapy based on individual molecular biology.Semantic proximity Read ↗

Recent advances in autosomal-dominant polycystic kidney disease.Semantic proximity Read ↗

Congenital nephrogenic diabetes insipidus: what can we learn from mouse models?Semantic proximity Read ↗

Renin-Angiotensin-Aldosterone System Antagonism and Polycystic Kidney Disease Progression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.